ATE151426T1 - Generserin-derivate als cholinesterase-hemmer - Google Patents

Generserin-derivate als cholinesterase-hemmer

Info

Publication number
ATE151426T1
ATE151426T1 AT92916772T AT92916772T ATE151426T1 AT E151426 T1 ATE151426 T1 AT E151426T1 AT 92916772 T AT92916772 T AT 92916772T AT 92916772 T AT92916772 T AT 92916772T AT E151426 T1 ATE151426 T1 AT E151426T1
Authority
AT
Austria
Prior art keywords
pct
group
sec
generserin
derivatives
Prior art date
Application number
AT92916772T
Other languages
English (en)
Inventor
Paolo Chiesi
Canale Maurizio Del
Vittorino Servadio
Eleonora Ghidini
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE151426T1 publication Critical patent/ATE151426T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
AT92916772T 1991-08-09 1992-08-04 Generserin-derivate als cholinesterase-hemmer ATE151426T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912237A IT1251166B (it) 1991-08-09 1991-08-09 Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ATE151426T1 true ATE151426T1 (de) 1997-04-15

Family

ID=11360556

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92916772T ATE151426T1 (de) 1991-08-09 1992-08-04 Generserin-derivate als cholinesterase-hemmer

Country Status (20)

Country Link
US (1) US5538968A (de)
EP (1) EP0599890B1 (de)
JP (1) JP3172185B2 (de)
KR (1) KR100225927B1 (de)
AT (1) ATE151426T1 (de)
AU (1) AU659865B2 (de)
CA (1) CA2115250A1 (de)
CZ (1) CZ281018B6 (de)
DE (1) DE69218949T2 (de)
DK (1) DK0599890T3 (de)
ES (1) ES2101858T3 (de)
FI (1) FI107532B (de)
GR (1) GR3023838T3 (de)
HK (1) HK1006714A1 (de)
HU (1) HU222774B1 (de)
IT (1) IT1251166B (de)
NO (1) NO303175B1 (de)
NZ (1) NZ243869A (de)
WO (1) WO1993003041A1 (de)
ZA (1) ZA925903B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ503773A (en) * 1997-10-10 2002-05-31 Chiese Farmaceutici S A process for the preparation of aminocarbonyl derivatives of geneseroline having selective brain anticholinesterase activity
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10000577A1 (de) * 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
JP2004523511A (ja) * 2001-01-12 2004-08-05 フーマファーム アーゲー フマル酸アミド類
DE10101307A1 (de) * 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
BRPI0410805A (pt) 2003-09-09 2006-06-27 Fumapharm Ag uso de derivados do ácido fumárico para tratamento da insuficiência cardìaca e asma
US7897639B2 (en) * 2003-10-21 2011-03-01 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
EP2125709A2 (de) * 2007-02-02 2009-12-02 Colucid Pharmaceuticals, Inc. Verbindungen zur hemmung von cholinesterase
EP3135282A1 (de) * 2007-02-08 2017-03-01 Biogen MA Inc. Nervenschutz bei entmarkungserkrankungen
HRP20220902T3 (hr) 2007-02-08 2022-10-14 Biogen Ma Inc. Pripravci i njihova upotreba u liječenju multiple skleroze
US20090048229A1 (en) * 2007-07-18 2009-02-19 Rupniak Nadia M J Methods for promoting wakefulness
US8593728B2 (en) * 2009-02-19 2013-11-26 Toyota Motor Engineering & Manufacturing North America, Inc. Multilayer photonic structures
EA037187B1 (ru) 2010-02-09 2021-02-17 Дзе Джонс Хопкинс Юниверсити Способ и композиция для лечения когнитивного расстройства
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
HUE040044T2 (hu) 2013-03-14 2019-02-28 Alkermes Pharma Ireland Ltd Fumarátok prodrugjai, és azok alkalmazása különbözõ betegségek kezelésében
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2014144801A1 (en) 2013-03-15 2014-09-18 Agenebio Inc. Methods and compositions for improving cognitive function
US9604922B2 (en) 2014-02-24 2017-03-28 Alkermes Pharma Ireland Limited Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
US10925834B2 (en) 2015-05-22 2021-02-23 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374908A1 (fr) * 1976-12-21 1978-07-21 Theranol Lab Medicament constitue par l'association optimale d'une substance vagomimetique, le salicylate d'amine-oxyde d'eserine, et d'une substance potentialisant la secretion gastrique, le chlorhydrate d'acide glutamique
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina

Also Published As

Publication number Publication date
JPH06509572A (ja) 1994-10-27
KR100225927B1 (ko) 1999-10-15
US5538968A (en) 1996-07-23
NO940415L (no) 1994-04-06
AU659865B2 (en) 1995-06-01
IT1251166B (it) 1995-05-04
ITMI912237A1 (it) 1993-02-10
CZ26294A3 (en) 1994-07-13
DE69218949T2 (de) 1997-09-18
FI940573A (fi) 1994-03-28
FI107532B (fi) 2001-08-31
ZA925903B (en) 1993-04-28
NO940415D0 (no) 1994-02-08
JP3172185B2 (ja) 2001-06-04
HU222774B1 (hu) 2003-10-28
HU9400353D0 (en) 1994-06-28
WO1993003041A1 (en) 1993-02-18
GR3023838T3 (en) 1997-09-30
HK1006714A1 (en) 1999-03-12
ITMI912237A0 (it) 1991-08-09
DK0599890T3 (da) 1997-10-20
DE69218949D1 (de) 1997-05-15
EP0599890A1 (de) 1994-06-08
CA2115250A1 (en) 1993-02-18
CZ281018B6 (cs) 1996-05-15
ES2101858T3 (es) 1997-07-16
EP0599890B1 (de) 1997-04-09
NO303175B1 (no) 1998-06-08
FI940573A0 (fi) 1994-02-08
AU2387692A (en) 1993-03-02
NZ243869A (en) 1994-03-25
HUT70414A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
ATE151426T1 (de) Generserin-derivate als cholinesterase-hemmer
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
HU9600278D0 (en) Remedy for nervous diseases
DE3869907D1 (de) Chinolincarbonsaeure-derivate.
ATE120955T1 (de) Benzyliden-malononitril-derivate zur hemmung von proliferativen prozessen in säugetierzellen.
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
DK152090D0 (da) Piperidylsubstituerede indolderivater
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
DK671688A (da) 2-(piperazinyl)-2-oxoethylensubstituerede flavonoidderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
ATE128462T1 (de) Cyclische hydroxamsaeuren und ihre verwendung.
DK314483A (da) Peenem-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
ATE146481T1 (de) Epoxysuccinamidsäurederivat
ES2043820T3 (es) Nuevas 1-1 alkil-1-sulfonil-2-alkoxicarbonilsulfenilhidrazinas que tienen actividad antineoplastica.
ATE92468T1 (de) Zimtsaeureamid-derivate.
KR890009890A (ko) 하이드록시 피리미딘의 아실 유도체
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
DK0596917T3 (da) Benzimidazolanthelmintika
ATE178322T1 (de) Isoxazolcarbonsäureamide, verfahren zu ihrer herstellung und ihre verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee